Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A reference pricing system for Ireland.

Usher C, Barry M.

Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):675-7. doi: 10.1586/erp.12.66. No abstract available.

PMID:
23252350
2.

Public drug expenditure in the Republic of Ireland.

Barry M, Usher C, Tilson L.

Expert Rev Pharmacoecon Outcomes Res. 2010 Jun;10(3):239-45. doi: 10.1586/erp.10.23.

PMID:
20545588
3.

[Regresses for medicine prescription: benchmark evaluations should be eliminated].

Dryden WA.

MMW Fortschr Med. 2013 Nov 14;155 Spec No 2:16. German. No abstract available.

PMID:
24734441
4.

Pricing and reimbursement of drugs in Ireland.

Barry M, Tilson L, Ryan M.

Eur J Health Econ. 2004 Jun;5(2):190-4.

PMID:
15452757
5.

[Reimbursement of generics in Croatia: should more have been done?].

Vukusić M.

Lijec Vjesn. 2010 May-Jun;132(5-6):134-43. Croatian.

PMID:
20677618
6.

Impact of European pharmaceutical price regulation on generic price competition: a review.

Puig-Junoy J.

Pharmacoeconomics. 2010;28(8):649-63. doi: 10.2165/11535360-000000000-00000. Review.

PMID:
20515079
7.

The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland.

Tilson L, Bennett K, Barry M.

Eur J Health Econ. 2005 Sep;6(3):267-73.

PMID:
15977036
8.

Do users of risperidone who switch brands because of generic reference pricing fare better or worse than non-switchers? A New Zealand natural experiment.

Lessing C, Ashton T, Davis P.

Adm Policy Ment Health. 2015 Nov;42(6):695-703. doi: 10.1007/s10488-014-0606-9.

PMID:
25331449
9.

Generic substitution of antiepileptic drugs.

Sander JW, Ryvlin P, Stefan H, Booth DR, Bauer J.

Expert Rev Neurother. 2010 Dec;10(12):1887-98. doi: 10.1586/ern.10.163. Review.

PMID:
21091318
10.

The high cost of medicines in Ireland. Is it time to change the pricing mechanism?

Tilson L, McGowan B, Bennett K, Barry M.

Eur J Health Econ. 2004 Dec;5(4):341-4.

PMID:
15452737
11.

Is all "skin in the game" fair game? The problem with "non-preferred" generics.

Oster G, Fendrick AM.

Am J Manag Care. 2014 Sep;20(9):693-5. No abstract available.

12.

Generic and therapeutic substitution: a response to our critic.

Al Ameri MN, Epstein M, Johnston A.

Int J Clin Pharm. 2011 Dec;33(6):881. doi: 10.1007/s11096-011-9564-4. Epub 2011 Sep 17. No abstract available.

PMID:
21927801
13.

[Drug costs in Germany: 12 poorer countries are the benchmark].

Laschet H.

MMW Fortschr Med. 2012 Nov 29;154(21):12. German. No abstract available.

PMID:
23270047
14.

[Adjustment of antihypertensive therapy to a generic eprosartan preparation. Results of a non-interventional study].

Nüdling S, Kahner-Gröne S, Köneke D, Marggraf K, Palissa H.

MMW Fortschr Med. 2010 Oct 14;152 Suppl 3:96-101. German. No abstract available.

PMID:
21595153
15.
16.

Generic and therapeutic substitution: ethics meets health economics.

Simoens S.

Int J Clin Pharm. 2011 Jun;33(3):469-70. doi: 10.1007/s11096-011-9500-7. Epub 2011 Mar 24. No abstract available.

PMID:
21431935
17.

The effect of introducing inpatient mandatory generic drug substitution at Ramathobodi Hospital.

Kaojarern S, Pattanaprateep O.

J Med Assoc Thai. 2012 Apr;95(4):519-25.

PMID:
22612005
18.

Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme.

Searles A, Jefferys S, Doran E, Henry DA.

Med J Aust. 2007 Aug 20;187(4):236-9. Epub 2007 Jun 13. Review.

PMID:
17564580
19.

Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.

Wu EQ, Yu AP, Lauzon V, Ramakrishnan K, Marynchenko M, Ben-Hamadi R, Blum S, Erder MH.

Ann Pharmacother. 2011 Apr;45(4):441-51. doi: 10.1345/aph.1P482. Epub 2011 Mar 17.

PMID:
21415162
20.

The impact of reference-pricing systems in Europe: a literature review and case studies.

Dylst P, Vulto A, Simoens S.

Expert Rev Pharmacoecon Outcomes Res. 2011 Dec;11(6):729-37. doi: 10.1586/erp.11.70. Review.

PMID:
22098289

Supplemental Content

Support Center